# Conducting Clinical Trials of the Medicine "Rutan Tablets 0.1g" No. 10 in the Complex Therapy of COVID-19

> **NCT05859919** · PHASE2 · COMPLETED · sponsor: **Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan** · enrollment: 57 (actual)

## Conditions studied

- Patients With COVID-19

## Interventions

- **DRUG:** The drug "Rutan 0.1".
- **OTHER:** Basic treatment

## Key facts

- **NCT ID:** NCT05859919
- **Lead sponsor:** Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-12
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05859919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05859919, "Conducting Clinical Trials of the Medicine "Rutan Tablets 0.1g" No. 10 in the Complex Therapy of COVID-19". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05859919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*